NM

Newtyn Management Portfolio holdings

AUM $945M
1-Year Est. Return 41.04%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+41.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$817M
AUM Growth
+$157M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$83.9M
2
+$33.3M
3
+$27.2M
4
AIV
Aimco
AIV
+$20.9M
5
GLIBK
GCI Liberty Inc Series C
GLIBK
+$12.9M

Top Sells

1
+$23M
2
+$20M
3
+$10.5M
4
CMP icon
Compass Minerals
CMP
+$8.22M
5
SAGE
Sage Therapeutics
SAGE
+$6.38M

Sector Composition

1 Healthcare 36.25%
2 Communication Services 17.81%
3 Real Estate 14.43%
4 Consumer Discretionary 9.06%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NODK icon
26
NI Holdings
NODK
$274M
$9.09M 1.11%
670,000
RCKT icon
27
Rocket Pharmaceuticals
RCKT
$542M
$8.16M 1%
2,502,863
+502,863
SCPH
28
DELISTED
scPharmaceuticals
SCPH
$5.33M 0.65%
+940,568
AEBI
29
Aebi Schmidt Holding AG
AEBI
$1.12B
$2.76M 0.34%
+221,100
WVE icon
30
Wave Life Sciences
WVE
$2.59B
$2.2M 0.27%
300,000
-100,000
AVIR icon
31
Atea Pharmaceuticals
AVIR
$366M
$1.43M 0.17%
492,284
-87,716
ABEO icon
32
Abeona Therapeutics
ABEO
$277M
$1.31M 0.16%
248,656
-231,344
MURA
33
DELISTED
Mural Oncology
MURA
$1.08M 0.13%
522,919
-47,081
AMN icon
34
AMN Healthcare
AMN
$748M
– –
-287,038
DV icon
35
DoubleVerify
DV
$1.7B
– –
-700,000
ITOS
36
DELISTED
iTeos Therapeutics
ITOS
– –
-567,416
KROS icon
37
Keros Therapeutics
KROS
$432M
– –
-246,857
MITK icon
38
Mitek Systems
MITK
$661M
– –
-484,954
SAGE
39
DELISTED
Sage Therapeutics
SAGE
– –
-700,000
MRP
40
Millrose Properties Inc
MRP
$5.21B
– –
-807,135
1
2